Research Projects & Grants

For Profit Organization

• An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Participants with Moderately to Severely Active Ulcerative Colitis, Role: Investigator, Arena Pharmaceuticals, Inc., (05/2026 - 05/2027) Status: Approved
• A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis with an Inadequate Response to Conventional Therapy, Role: Investigator, Celgene, Inc., (01/2026 - 01/2027) Status: Approved
• A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease, Role: Investigator, Takeda America Research and Development Center Inc., (02/2026 - 02/2027) Status: Approved